PEDV modulates the host innate immune system by suppressing the type I interferon production and ISGs expression.
Ten viral proteins were identified as IFN antagonists, and nsp1 was the most potent viral IFN antagonist.
PEDV nsp1 did not interfere the IRF3 phosphorylation and nuclear translocation but interrupted the enhanceosome assembly of IRF3 and CREB-binding protein (CBP).
PEDV nsp1 caused the CBP degradation in the nucleus, which may be the key mechanism for PEDV-mediated IFN downregulation.